664 results
Presenters: Kevin Saunders, Shannon Miller, Josphat Kosgei, Marion Gruber
Presenters Nicolas Collin, Daniel Fullen, Dexiang Chen, Krishna Mohan, Paulo Lee Ho
Presenters: Wolfgang Leitner, David Burkhart, Nikolai Petrovsky, Sunil David, Gabriel Pedersen, Mangala Rao, Chad Costley, Elizabeth Norton, Robert Ernst, Celine Lemoine, Christopher Fox
This webinar is to discuss issues related to global demand for vaccine adjuvants and the associated research and development, as well as facilitating global access to novel adjuvants and formulation...
Yellow Fever Confirmatory Testing Algorithm for Regional Reference Laboratories
The summary agenda of the 17th TechNet Conference that will take place in Panama City in October 2023. This version was updated on 18-08-2023.
Abstract
Background
The Immunization Agenda 2030 (IA2030) Impact Goal 1.1. aims to reduce the number of future deaths averted through immunization in the next decade. To estimate the potential...
This webinar is to discuss issues related to global demand for vaccine adjuvants and the associated research and development, as well as facilitating global access to novel adjuvants and formulation...
n the past several years, as worldwide morbidity and mortality due to malaria have continued to decrease, the global malaria community has grown increasingly supportive of the idea of malaria...
The global incidence of JE is unknown because the intensity and quality of JE surveillance and the availability of diagnostic laboratory testing vary throughout the world. Countries that have...
This paper—designed for use by US executive branch officials, members of Congress, advocates, and other stakeholders— presents an analysis of the USG’s role in global immunization and offers...
Vaccine has published a supplement entitled “Rotavirus Surveillance, Safety, and Economic Data before Vaccine Introduction: a Global Perspective from the World Health Organization Global Rotavirus...
This Findings Report includes an overview of the MOMENTUM Routine Immunization Transformation and Equity project’s global mapping of private sector interventions supporting COVID-19 efforts,...
Bioterrorism is the deliberate release of biological toxins, pathogenic viruses, bacteria, parasites, or other infectious agents into the public sphere with the objective of causing panic, illness,...
Margaret Chan (WHO), T. Evans (World Bank)
Over the past several years, the development of new vaccines, along with global efforts to make them more available and affordable, has resulted in the introduction of lifesaving vaccines in...
In 1988, the World Health Assembly resolved to eradicate poliomyelitis worldwide (1). One of the main tools used in polio eradication efforts has been the live, attenuated, oral poliovirus vaccine...
APPROCHE DÉDIÉE À LA PRESTATION DES SERVICES DE VACCINATION CONTRE LA COVID-19 DE LA ZAMBIE: UTILISER LA GÉNÉRATION DE DEMANDE ASCENDANTE POUR ATTEINDRE CHAQUE PERSONNE ADMISSIBLE
W. Hanekom (BMGF), E. Hanon (GSK), I. Jonsdottir (U. Hospital Iceland), D. Lewis (U. Surrey), P. Neels (consultant), B. Pulendran (Emory U.)
The effort towards improving the health of the population in Kenya continues to produce results driven by accurate and timely data. Over the past three decades, the country has witnessed impressive...
Integration of COVID-19 vaccination into routine immunization and primary health care
The Addis Declaration on Immunization calls for countries to increase political and
financial investments in their immunization programmes. It includes 10 commitments,
including increasing...
The study concludes that global health is improving. Population growth and ageing have driven up numbers of DALYs, but crude rates have remained relatively constant, showing that progress in health...
In 2011, the story of immunisation coverage worldwide hovers between the glass half empty and the glass half full. Anticipated advances in vaccinology during this new Decade of Vaccines will only...
In mid-April of 1958 the Government of Pakistan summoned the press to announce a grave need for international aid to cope with smallpox and cholera epidemics in East Pakistan. In response, and with...
Overcoming challenges of new technology/vaccine introduction and country preparedness - case study of Kenya
Improving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends. The Global Burden of Disease 2015 Study (GBD 2015)...
Following the decision to leave the EU, the UK will be even more engaged internationally. The multilateral system is vital to the UK and global interests and we will continue to be a committed...
Nearly all of the 500,000 new cases of cervical cancer and 270,000 deaths occur in middle or lower income countries. Yet the two most prevalent HPV vaccines are unaffordable to most. Even prices to...
Background: In preparation for the introduction of MenAfriVac, a meningococcal group A conjugate vaccine developed for the African meningitis belt, an enhanced meningitis surveillance network was...
The Polio Eradication and Endgame Strategic plan outlines the phased removal of oral polio vaccines (OPVs), starting with type 2 poliovirus–containing vaccine and introduction of inactivated polio...
Performance-based financing: just a donor fad or a catalyst towards comprehensive health-care reform
The United Nations Millennium Development Goals are approaching their deadline of 2015 but progress to date has been insufficient. Public expenditure on health – both domestic and official...
Progress in nucleic acid vaccines, room for innovation, and where to go from here
In 1796, Edward Jenner developed the smallpox vaccine consisting of pustular material obtained from lesions on cows affected by so-called cow-pox. The disease, caused by cowpox virus, confers...
0:00 - Controlled human malaria infection—tool for accelerating vaccine development, Melissa Kapulu.
20:52 - Typhoid controlled human infection model, Andrew Pollard.
35:04 - Respiratory virus...
0:00 - Anant Shah, Merck.
21:52 - Ahd Hamidi, Batavia Biosciences.
37:41 - Casey Selwyn, Bill & Melinda Gates Foundation.
54:32 - Block 1 Q&A, Antu Dey, Anant Shah, Ahd Hamidi, Casey...
0:00 - A conversation on the challenges and opportunities for innovation in vaccination, Jon Abramson and Alejandro Cravioto.
9:24 - Transformative concepts for mass vaccination and pandemic...
0:36 - Introduction.
3:43 - The enduring dilemma of 20 million unvaccinated children: Equity and access solutions in IA2030, Kate O'Brien, WHO.
24:18 - Impact of COVID-19 on coverage and equity,...
0:00 - Ana Maria Henao =-Restrepo, WHO.
16:11 - Melanie Saville, CEPI.
34:20 - Barney Graham, NIAID/NIH.
54:35 - Block 1 Q&A, Helen Rees, Ana Maria Henao-Restrepo, Melanie Saville, Barney...
Narendra Arora, INCLEN; Naor Bar-Zeev, WHO; Rudzani Muloiwa, U. Cape Town; Deborah Watson-Jones, LSHTM
Stephen Thomas (WRAIR), Peter Smith (LSHTM), Gandi Rayón Ramírez (COFEPRIS), Chris Nelson (Sanofi Pasteur) Kwasi Amfo (Takeda), Alex Precioso (Butantan), Hasitha Tissera (Sri Lanka MOH)
M. Gottleib, D. Kristensen, R. Lagos, O. Popova, O. Ronveaux, D. Zehrung
Martin Friede, Emmanuel Hanon, Suresh Jadhav, Kenneth Kelly, Odile Leroy, Margaret McGlynn, Michael Mowatt, Sanjay Singh, Johan van hoof, Michael Watson
V. Ahonkhai, N. Baylor, M. Gruber, T. Jivapaisarnpong, H. Rees, D. Wood
N. Baylor (Biologics Consulting), Seth Berkley (Gavi), Lucille Blumberg (South Africa National Institute for Communicable Diseases), Marco Cavaleri (EMA), Mimi Darko (FDA Ghana), Swati Gupta (Merck),...